Moderate anemia at diagnosis is an independent prognostic marker of the EUTOS, Sokal, and Hasford scores for survival and treatment response in chronic-phase, chronic myeloid leukemia patients with frontline imatinib.
about
Moderate anemia at diagnosis is an independent prognostic marker of the EUTOS, Sokal, and Hasford scores for survival and treatment response in chronic-phase, chronic myeloid leukemia patients with frontline imatinib.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Moderate anemia at diagnosis i ...... ients with frontline imatinib.
@en
Moderate anemia at diagnosis i ...... ients with frontline imatinib.
@nl
type
label
Moderate anemia at diagnosis i ...... ients with frontline imatinib.
@en
Moderate anemia at diagnosis i ...... ients with frontline imatinib.
@nl
prefLabel
Moderate anemia at diagnosis i ...... ients with frontline imatinib.
@en
Moderate anemia at diagnosis i ...... ients with frontline imatinib.
@nl
P2093
P2860
P1476
Moderate anemia at diagnosis i ...... ients with frontline imatinib.
@en
P2093
Chia-Jen Liu
Jin-Hwang Liu
Jyh-Pyng Gau
Liang-Tsai Hsiao
Man-Hsin Hung
Po-Min Chen
Po-Shen Ko
Tzeon-Jye Chiou
Yao-Chung Liu
Yi-Tsui Wu
P2860
P304
P356
10.1080/03007995.2017.1356708
P407
P50
P577
2017-07-18T00:00:00Z